HCC → FXR−/− → BSEP functional deficiency → Upregulation of MDR1 and MRP1 expression → Regorafenib efflux increased → Intracellular regorafenib concentration reduced → HCC drug resistance. The gene discussed is ABCB11; the disease is hepatocellular carcinoma.